Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar
NCT07077681
·
clinicaltrials.gov ↗
RECRUITING
Status
246
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn Disease (CD)
Sponsor
EG Labo